Lieff Cabraser Civil Justice Blog
Brendan Glackin to Speak at January 2018 PLI Basic Negotiation Skills Seminar

Brendan Glackin to Speak at January 2018 PLI Basic Negotiation Skills Seminar

Lieff Cabraser partner Brendan P. Glackin will be participating in the Practising Law Institute’s (PLI) Basic Negotiation Skills 2018 Seminar on January 10 in San Francisco, California. Mr. Glackin will be featured on a distinguished slate of guests, presenting as part of a panel and live webcast titled “Strategizing Before a Negotiation” which will focus on how to prepare in advance of any negotiation, setting the goals and parameters of a negotiation, and how to consider the other side’s perspectives.

Attendees will learn the six steps of successful negotiation, how to organize a strategy for negotiating, identifying the three different types of negotiation skills, creating and using currencies during a negotiation, bargaining and offering concessions effectively, preparing tactics and avoiding ploys during negotiation, and considering alternatives to trial. Other panel topics include negotiation types and processes, the ethics of negotiation, setting the climate and flexing your communication and negotiation style, mastering tactics of effective negotiating, and alternative dispute resolutions and mediations.

Founded in 1933, the Practising Law Institute (PLI) is a nonprofit organization that furthers legal education and professional business training for attorneys and professionals in the legal realm. It is dedicated to providing the legal community with advanced education through seminars, workshops, live webcasts, and on-demand learning. You can sign up for the January 10 seminar here.

About Brendan Glackin

A partner in Lieff Cabraser’s San Francisco office, Mr. Glackin represented direct purchasers of titanium dioxide in a nationwide antitrust class action lawsuit; direct purchasers of flat-panel TV screens in litigation against the world’s leading LCDs manufacturers for conspiring to fix prices; retailers in a monopolization pricing lawsuit against Abbott Laboratories charging that the company exploited the market for AIDS medicines used in conjunction with Abbott’s prescription drug Norvir, and represented employees in the high-tech workers class action alleging that major Silicon Valley firms colluded to reduce competition for workers. He presently serves on the Lieff Cabraser team representing The Charles Schwab Corporation in the LIBOR manipulation suit.